---
category: news
title: "Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid"
excerpt: "Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability"
publishedDateTime: 2023-04-26T22:57:00Z
originalUrl: "https://www.prnewswire.co.uk/news-releases/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-301808935.html"
webUrl: "https://www.prnewswire.co.uk/news-releases/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-301808935.html"
type: article

provider:
  name: PR Newswire
  domain: prnewswire.co.uk

topics:
  - Machine Learning
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?p=facebook"
    width: 629
    height: 329
    isCached: true

secured: "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;lwnktbylTloFXhOIj1KrhA=="
---

